Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced ...
International momentum is evidenced by the 2026 symposium attracting participants from 73 countries, and highlighting OGM ...
Earnings call Bionano Genomics delivered Q1 2026 revenue of $6.7M, up 4% YoY and at the high end of guidance, with consumable revenue up 20% and flow cell unit sales up 17%. Adjusted gross margin ...
Researchers at University Medical Center Utrecht have uncovered a previously underappreciated mechanism that helps immune ...
An international research team has succeeded in developing a new version of RNA building blocks with higher chemical reactivity and photosensitivity. This can significantly reduce the production time ...
A new technology allows scientists to map, in single cells, the DNA binding sites of transcription factors and other regulatory proteins that control gene activity, according to a study led by ...
Researchers have developed a technique that can identify errors caused by mutations linked to a range of genetic disorders, including forms of muscular dystrophy, Huntington's disease and amyotrophic ...
Max Planck will use Roche’s Genome Sequencer 20 system to produce a draft genome sequence for the Bonobo or Pygmy Chimpanzee. with the Breaking Science News daily newsletter ...
Hosted on MSN
Living DNA vs. Whole Genome Sequencing: Choosing the Right DNA Test for Your 2026 Tech Journey
As 2026 brings AI-driven genealogy tools to the mainstream, the decision between a Living DNA genotyping kit and full whole-genome sequencing is no longer just about ancestry percentages—it's about ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results